Skip to main content

Table 1 Number of cardiovascular medications by different patient characteristics

From: Cardiovascular polypharmacy is not associated with unplanned hospitalisation: evidence from a retrospective cohort study

   Percentage of patients in each group on different numbers of cardiovascular drugs
  Number of patients (% of total) None 1 or 2 3 or 4 5 or 6 7 or more
All patients 180815 74.6% 11.9% 7.8% 4.0% 1.7%
Gender       
 Female 91739 (50.7%) 72.7% 14.1% 8.0% 3.7% 1.6%
 Male 89076 (49.3%) 76.6% 9.7% 7.6% 4.2% 1.9%
Age, years       
 20 to 39 55901 (30.9%) 97.7% 2.0% 0.3% 0.1% 0.02%
 40 to 59 68525 (37.9%) 83.0% 10.7% 4.1% 1.5% 0.6%
 60 to 79 45133 (25.0%) 46.1% 21.9% 17.9% 9.8% 4.3%
 80 or more 11256 (6.2%) 23.4% 29.1% 26.8% 14.4% 6.2%
Deprivation quintile       
 1, least deprived 31121 (17.2%) 78.8% 10.8% 6.5% 2.8% 1.0%
 2 37261 (20.6%) 75.3% 12.1% 7.6% 3.6% 1.4%
 3 45823 (25.3%) 73.6% 12.3% 8.1% 4.1% 1.8%
 4 36098 (20.0%) 72.7% 12.4% 8.4% 4.4% 2.0%
 5, most deprived 30512 (16.9%) 73.2% 11.8% 8.1% 4.7% 2.3%
Cardiovascular condition       
 Hypertension 36859 (20.4%) 12.7% 35.9% 30.0% 14.9% 6.5%
 IHD 12353 (6.8%) 4.8% 11.5% 31.1% 33.0% 19.6%
 Stroke/TIA 5800 (3.2%) 10.9% 21.8% 32.6% 22.7% 12.0%
 PVD 5473 (3.0%) 28.6% 21.7% 22.7% 17.1% 9.8%
 Atrial fibrillation 3919 (2.2%) 7.8% 15.6% 27.7% 27.3% 21.6%
 Heart failure 3673 (2.0%) 5.1% 14.2% 26.3% 29.6% 24.9%
Non-cardiovascular comorbidity count       
 None 74230 (41.2%) 90.6% 5.3% 2.8% 1.1% 0.3%
 1 44184 (24.4%) 77.3% 11.5% 7.0% 3.1% 1.1%
 2 27199 (15.0%) 64.1% 16.6% 11.5% 5.6% 2.3%
 3 16217 (9.0%) 53.1% 20.5% 14.7% 8.1% 3.6%
 4 9357 (5.2%) 44.8% 23.5% 16.6% 10.2% 5.0%
 5 or more 9628 (5.3%) 34.3% 26.3% 19.6% 12.5% 7.3%
Non-cardiovascular drug count       
 None 87702 (48.5%) 89.8% 5.9% 3% 1% 0.3%
 1 to 3 61015 (33.7%) 70.1% 14.4% 9.3% 4.5% 1.7%
 4 to 6 19311 (10.7%) 47.4% 22.3% 16.4% 9.7% 4.2%
 7 to 9 7549 (4.2%) 35.6% 24.7% 20.3% 12.5% 6.9%
 10 or more 5238 (2.9%) 29.4% 27.6% 21.2% 13.2% 8.6%
  1. IHD, ischaemic heart disease; TIA, transient ischaemic attack; PVD, peripheral vascular disease.